Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Nicotine Gel (ATG002) in Plantar Diabetic Foot Ulcers
NCT00316537Phase 2Terminated
- Sponsor
- CoMentis, Inc.
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine in diabetic foot ulcer (DFU), sponsored by CoMentis, Inc.. Started Oct 2006; status: terminated.
02
Drugs
nicotine
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00316537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316537.